Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area;Doença hepática gordurosa não alcoólica em pacientes com doença coronariana de uma área do nordeste do Brazil

Arquivos de Gastroenterologia

Volumn 52, Issue 2, 2015, Pages 111-116

  Vilar, Consuêlo Padilha ^a,b   Cotrim, Helma Pinchemel ^a   Florentino, Gesira Soares Assis ^a,b   Bragagnoli, Gerson ^a,b   Schwingel, Paulo Adriano ^a   Barreto, Cibelle Padilha Vilar ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

Author keywords

Cardiovascular diseases; Coronary angiography; Coronary artery disease; Fatty liver

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BRAZIL; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR; SMOKING; COMPLICATION; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

BRAZIL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS;

EID: 84930515495     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032015000200007     Document Type: Article

References (30)

1. Açikel M, Sunay S, Koplay M, Gindoğdu F, Karakelleoğlu S. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg. 2009;9(4):273-9.
2. Agrawal S, Duseja AK. Non-alcoholic Fatty Liver Disease: East Versus West. J Clin Exp Hepatol. 2012;2:122-34.
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classif cation of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of aWHO consultation. Diabet Med. 1998;15(7):539-53.
4. Alper AT, Hasdemir H, Sahin S, Onturk E, Akyol A, Nurkalem Z, et al. The relationship between nonalcoholic fatty liver disease and the severity of CAD in patients with metabolic syndrome. Turk Kardiyol DernArs. 2008;36(6):376-81.
5. Arslan U, Türkoğlu S, Balcioğlu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18(6):433-6.
6. Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(7):1724-45.
7. Băloşeanu CL, Streba CT, Vere CC, Comănescu V, Rogoveanu I. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom JMorpholEmbryol. 2012;53(3):609-14
8. Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L, et al. Nonalcoholic Steatohepatitis Clinical Research Network Research Group. Ethnicity and nonalcoholic fatty liver disease. Hepatology. 2012;55(3):769-80.
9. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95.
10. Chan WK, Bahar N, Razlan H, Vijayananthan A, Sithaneshwar P, Goh KL. Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males. Hepatol Int. 2014;8:121-7.
11. Feitosa MF, Reiner AP, Wojczynski MK, Graff M, North KE, Carr J et al. Sex-infuenced association of nonalcoholic fatty liver disease with coronary heart disease. Atherosclerosis. 2013;227(2):420-4.
12. Ferreira VS, Pernambuco RB, Lopes EP, Morais CN, Rodrigues MC, Arruda MJ, et al. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2010;54(4):362-8.
13. Guidorizzi de Siqueira AC, Cotrim HP, Rocha R, Carvalho FM, deFreitas LA, Barreto D, et al. Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum. Eur J GastroenterolHepatol. 2005;17(8):837-41.
14. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13(10):1579-84.
15. Marfell-Jones M, Olds T, Stewart A, Carter L. International standards for anthropometric assessment. Potchefstroom, South Africa: International Society for the Advancement of Kinanthropometry. 2006:1-137.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;2(22):3476-83.
17. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14(22):3476-83.
18. National Cholesterol Education Program (NCEP), National Heart, Lung and Blood Institute, National Institutes of Health. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106(25):3143-421.
19. Pacifco L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr. 2007;96(4):542-7.
20. Perez M, Gonzáles L, Olarte R, Rodriguez NI, Tabares M, Salazar JP, et al. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. Prev Med. 2011;52(2):174-7.
21. Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Pérez-Ayuso RM, et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 2009;29(1):82-8.
22. Salgado AL, Carvalho LD, Oliveira AC, Santos VN, Vieira JG, Parise ER. Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. Arq Gastroenterol. 2010;47(2):165-9.
23. Sociedade Brasileirade Cardiologia; Sociedade Brasileira de Hipertensão; Sociedade BrasileiradeNefrologia. [VI Brazilian Guidelines on Hypertension]. Arq Bras Cardiol. 2010;95(1 Suppl):1-51.
24. Souza MR, Diniz M.F, Medeiros-Filho JE, Araújo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012;49(1):89-96.
25. Sun L, Lu SZ. Association between non-alcoholic fatty liver disease and CAD severity. Chin Med J (Engl). 2011;124(6):867-72.
26. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, et al. Relations Between CarotidArtery Wall Thickness and Liver Histology in Subjects With Nonalcoholic Fatty Liver Disease. Diabetes Care. 2006;29(6):1325-30.
27. Treeprasertsuk S, Lope Z; Jimenez F, Lindor KD. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci. 2011;56(1):35-45.
28. WHO Expert Committee on Physical Status. Physical Status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser. 1995;854:1-453.
29. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60(12):1721-7.
30. World Health Organization. Guidelines for the Conduct of tobacco-smoking among health professionals. Report WHO/SMO 84.1. Geneva: World Health Organization, 1984:1-19.